How to improve post-market surveillance on a global scale
This article was originally published in Clinica
Executive Summary
In the EU, the European Commission is encouraging member states to increase the exchange of National Competent Authorities Reports (NCARs). Its staff working document on the impact assessment on the revision of the regulatory framework for medical devices - published in September 2012 - also encourages them to share knowledge and competencies. In this article, Gabriel Adusei* makes a series of recommendations that could improve market surveillance and vigilance not only in the EU, but globally